Early Identification and Prognosis Prediction of Sepsis Through Multiomics
NCT ID: NCT05305469
Last Updated: 2024-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
900 participants
OBSERVATIONAL
2022-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Biomarker Prediction Model of Septic Risk in Infected Patients
NCT05095324
The Early Prediction of Sepsis in ICU
NCT05088850
BIomarkers to Predict the Outcomes of Sepsis
NCT05842980
Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.
NCT01687010
Early Recognition and Dynamic Risk Warning System of Multiple Organ Dysfunction Syndrome Caused by Sepsis
NCT04904289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GN
Gram-negative bacteria infection group
No interventions assigned to this group
GP
Gram-positive bacteria infection group
No interventions assigned to this group
Fungal
Fungal infection group
No interventions assigned to this group
Viral
Viral infection group
No interventions assigned to this group
Control
Non-sepsis group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18～85 years old.
Exclusion Criteria
* Female subjects who are pregnant;
* The subjects not sure if infected;
* The subjects performed CPR;
* The subjects suffer from chronic renal disease;
* The subjects with incomplete clinical data.
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yantai Yuhuangding Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jing Wang
Role: PRINCIPAL_INVESTIGATOR
Yantai Yuhuangding Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Wang J, Sun Y, Teng S, Li K. Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation. BMC Med. 2020 Apr 15;18(1):83. doi: 10.1186/s12916-020-01546-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.